InvestorsHub Logo
Followers 46
Posts 5225
Boards Moderated 0
Alias Born 01/27/2012

Re: attilathehunt post# 383143

Monday, 11/14/2022 12:19:49 PM

Monday, November 14, 2022 12:19:49 PM

Post# of 462901
My my my, all that came out of Dr. Misslings mouth was very positive in tone and when explaining the clinical outcomes met he was in one big continuous “not only this but, not only this but…….!”

1)continuing to emphasize that we are mirroring oncologys recent successful roadmap to treatments.

2) patients still 5+ years in the ph 2a still on the drug with data revealed only at 3 years. They know much more.

3) many biomarkers that have been found along the way and specifically point to strength when looking at the outcomes of the trials ie Gaba Glutamate levels, WT sr1, Tau, etc. (not new but well organized in a compiled manor)

4) framed a clear picture based on trials running what other diseases we would be successful in treating in the not to distant future. Lots of blank picture frames hanging ready to have disease “inserted”. (Again, a repeat but better emphasized imo)

Also I had just the opposite experience Attila in that I ended up hearing but not see and I am thankful as I got a much better feeling listening then seeing. After seeing the slide deck start and not being able to hear I had to “click” on “try another stream” with which the slides went away and the sound started.

Overall my take away is they actually are continuing to “MOVE BOLDLY forward!” and my main take away and change imo is, there is no more WGS but rather Im confident that WGT. We always have in the company’s mind and now in mine!

I apologise for the bit disjointed ramblings.

Cheers

>WGT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News